semaglutide oral for weight loss FDA Approves as the First Oral GLP-1 Pill US FDA accepts Novo Nordisk's

Myth #5: It Only Works If You Have Diabetes The Claim: These drugs are for diabetics, if you dont have diabetes they wont work for weight loss (Facebook group comment) The Reality: Retatrutides Phase 2 trial specifically enrolled participants without diabetes, and they achieved 24.2% average weight loss

OBES SURG 34 , 16531664 (2024)

SeekPeptides helps designing monitoring protocols for long-term neuroprotection

doi: 10.2147/JIR.S84993 42 ZhaoYYChenLHHuangLLiYZYangCZhuYet al

We still face several challenges: We need large-scale, randomized controlled trials specifically in RA, psoriasis, and PsA populations We need to understand the long-term effects of these drugs in autoimmune conditions We need to determine the optimal dosing and treatment duration for these new indications What This Means for You: A Personal Note As your rheumatologist, my primary concern is your well-being